CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML

Clinical trial NCT04151706 · COMPLETED

Trial details

NCT number: NCT04151706
Sponsor: Robert Lowsky
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Acute Leukemia Chronic Myeloid Leukemia

Start date: 2020-02-27
Primary completion: 2023-09-08
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.